A detailed history of Creative Planning transactions in United Therapeutics Corp stock. As of the latest transaction made, Creative Planning holds 3,935 shares of UTHR stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,935
Previous 3,613 8.91%
Holding current value
$1.46 Million
Previous $1.15 Million 22.61%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$311.04 - $363.55 $100,154 - $117,063
322 Added 8.91%
3,935 $1.41 Million
Q2 2024

Aug 15, 2024

BUY
$228.26 - $319.04 $138,097 - $193,019
605 Added 20.11%
3,613 $1.15 Million
Q1 2024

May 10, 2024

SELL
$210.76 - $249.51 $71,236 - $84,334
-338 Reduced 10.1%
3,008 $690,000
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $103,357 - $123,588
481 Added 16.79%
3,346 $735,000
Q3 2023

Nov 16, 2023

SELL
$211.82 - $248.24 $8,472 - $9,929
-40 Reduced 1.38%
2,865 $647,000
Q2 2023

Jul 21, 2023

BUY
$205.19 - $232.99 $101,569 - $115,330
495 Added 20.54%
2,905 $641,000
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $70,286 - $91,136
330 Added 15.87%
2,410 $539,000
Q4 2022

Feb 10, 2023

BUY
$205.95 - $280.43 $205,950 - $280,430
1,000 Added 92.59%
2,080 $578,000
Q3 2022

Nov 03, 2022

BUY
$203.3 - $244.17 $219,564 - $263,703
1,080 New
1,080 $226,000
Q2 2021

Aug 04, 2021

SELL
$170.47 - $211.93 $251,613 - $312,808
-1,476 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$153.94 - $174.85 $227,215 - $258,078
1,476 New
1,476 $247,000
Q3 2018

Oct 25, 2018

SELL
$113.81 - $129.46 $910,593 - $1.04 Million
-8,001 Closed
0 $0
Q2 2018

Jul 20, 2018

BUY
$101.14 - $118.31 $5,259 - $6,152
52 Added 0.65%
8,001 $905,000
Q1 2018

Apr 18, 2018

BUY
$107.21 - $151.94 $176,682 - $250,397
1,648 Added 26.15%
7,949 $893,000
Q4 2017

Jan 17, 2018

BUY
$118.58 - $151.28 $121,307 - $154,759
1,023 Added 19.38%
6,301 $932,000
Q3 2017

Oct 17, 2017

BUY
$114.6 - $136.81 $604,858 - $722,083
5,278
5,278 $619,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.